Ph-Byg ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  5.0% 5.0% 5.0% 5.0% 5.0%  
Bankruptcy risk  8.0% 10.0% 6.3% 7.2% 9.1%  
Credit score (0-100)  31 23 37 33 27  
Credit rating  BB BB BBB BBB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  577 1,119 681 2,052 5,507  
EBITDA  155 349 -59.7 299 228  
EBIT  144 349 -59.7 299 212  
Pre-tax profit (PTP)  143.5 345.5 -62.0 300.6 210.8  
Net earnings  109.1 256.1 -52.0 286.5 117.0  
Pre-tax profit without non-rec. items  144 345 -62.0 301 211  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  22.6 22.6 22.6 76.6 85.0  
Shareholders equity total  250 395 230 517 646  
Interest-bearing liabilities  0.0 31.5 0.0 0.0 0.0  
Balance sheet total (assets)  480 862 490 1,405 2,806  

Net Debt  -246 31.5 -165 -416 -633  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  577 1,119 681 2,052 5,507  
Gross profit growth  130.6% 93.8% -39.1% 201.2% 168.4%  
Employees  1 1 1 4 11  
Employee growth %  0.0% 0.0% 0.0% 300.0% 175.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  480 862 490 1,405 2,806  
Balance sheet change%  41.2% 79.4% -43.2% 186.9% 99.8%  
Added value  155.0 349.3 -59.7 299.4 228.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -23 0 0 54 -8  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 -1.0 1.0 2.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  24.9% 31.2% -8.8% 14.6% 3.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  35.3% 52.0% -8.8% 31.8% 10.1%  
ROI %  74.0% 102.4% -18.0% 79.3% 34.4%  
ROE %  55.8% 79.4% -16.6% 76.7% 20.1%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  52.0% 45.9% 47.1% 36.8% 23.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -158.7% 9.0% 277.1% -139.1% -277.3%  
Gearing %  0.0% 8.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 23.9% 15.8% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.7 1.5 1.6 1.5 1.3  
Current Ratio  1.7 1.5 1.6 1.5 1.3  
Cash and cash equivalent  245.9 0.0 165.4 416.4 633.3  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  166.8 231.3 147.3 402.0 578.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  155 349 -60 75 21  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  155 349 -60 75 21  
EBIT / employee  144 349 -60 75 19  
Net earnings / employee  109 256 -52 72 11